Birchbrook’s AbbVie ABBV Stock Holding History

Birchbrook’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$145K	Sell	577 -1,400	-71%	-$301K	0.07%	95
2026 Q1	$430K	Buy	1,977 +1	+0.1%	+$222	0.21%	58
2025 Q4	$452K	Hold	1,976	–	–	0.23%	55
2025 Q3	$457K	Buy	1,976 +1	+0.1%	+$204	0.24%	54
2025 Q2	$367K	Buy	1,975 +1	+0.1%	+$186	0.2%	57
2025 Q1	$414K	Hold	1,974	–	–	0.23%	52
2024 Q4	$351K	Buy	1,974 +1	+0.1%	+$184	0.2%	51
2024 Q3	$390K	Buy	1,973 +26	+1%	+$4.85K	0.22%	51
2024 Q2	$334K	Buy	1,947 +1	+0.1%	+$166	0.2%	52
2024 Q1	$354K	Buy	1,946 +1	+0.1%	+$172	0.21%	50
2023 Q4	$301K	Buy	+1,945	New	+$284K	0.2%	56

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Birchbrook's ABBV Position: Q2 2026 in Review

Birchbrook reduced its AbbVie (ABBV) stake by 71% in Q2 2026, selling an estimated $301K and leaving 577 shares worth $145K. The position accounts for 0.07% of the portfolio, ranked #95.

Birchbrook first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $457K in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Birchbrook held 577 shares of AbbVie worth $145K as of Q2 2026.
Birchbrook sold 1,400 AbbVie shares in Q2 2026, an estimated $301K.
AbbVie made up 0.07% of Birchbrook's portfolio in Q2 2026, its #95 holding.
Birchbrook first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Birchbrook's AbbVie position peaked at $457K in Q3 2025.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Birchbrook's 13F filing for Q2 2026, filed 9 Jul 2026.